- Home
- CODA vs IKNA Comparison
CODA vs IKNA Comparison
Compare CODA & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODA
- IKNA
- Stock Information
- Founded
- CODA 1994
- IKNA 2016
- Country
- CODA United States
- IKNA United States
- Employees
- CODA N/A
- IKNA N/A
- Industry
- CODA Industrial Machinery/Components
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- CODA Industrials
- IKNA Health Care
- Exchange
- CODA Nasdaq
- IKNA Nasdaq
- Market Cap
- CODA 92.5M
- IKNA 81.6M
- IPO Year
- CODA N/A
- IKNA 2021
- Fundamental
- Price
- CODA $7.78
- IKNA $1.48
- Analyst Decision
- CODA Strong Buy
- IKNA Buy
- Analyst Count
- CODA 1
- IKNA 2
- Target Price
- CODA $11.00
- IKNA $3.00
- AVG Volume (30 Days)
- CODA 28.8K
- IKNA 167.5K
- Earning Date
- CODA 03-17-2025
- IKNA 03-11-2025
- Dividend Yield
- CODA N/A
- IKNA N/A
- EPS Growth
- CODA 14.29
- IKNA N/A
- EPS
- CODA 0.32
- IKNA N/A
- Revenue
- CODA $20,316,161.00
- IKNA $659,000.00
- Revenue This Year
- CODA $31.72
- IKNA N/A
- Revenue Next Year
- CODA $12.23
- IKNA N/A
- P/E Ratio
- CODA $24.31
- IKNA N/A
- Revenue Growth
- CODA 4.98
- IKNA N/A
- 52 Week Low
- CODA $5.48
- IKNA $1.22
- 52 Week High
- CODA $9.89
- IKNA $1.94
- Technical
- Relative Strength Index (RSI)
- CODA 41.32
- IKNA 47.00
- Support Level
- CODA $7.75
- IKNA $1.40
- Resistance Level
- CODA $8.58
- IKNA $1.60
- Average True Range (ATR)
- CODA 0.27
- IKNA 0.07
- MACD
- CODA -0.00
- IKNA 0.01
- Stochastic Oscillator
- CODA 3.61
- IKNA 42.86
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. It operates in two segments: Marine Technology Business and Marine Engineering Business. The Technology Business develops proprietary solutions for both the commercial and defense subsea market. Its solutions include hardware and software for Geophysical Systems, Motion & Positioning Systems, and Real-Time Volumetric Imaging Sonar. The Engineering Business segment provides engineering services to a range of clients in the defense markets. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Marine Technology Business segment.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.